We are live on ! Find out more
GWM

Geneos Wealth Management Portfolio holdings

AUM $4.9B
1-Year Est. Return 23.65%
This Fund
S&P 500
This Quarter Est. Return
-5.21%
1 Year Est. Return
+23.65%
3 Year Est. Return
+66.72%
5 Year Est. Return
+71.27%
10 Year Est. Return
+298.51%
AUM
$1.45B
AUM Growth
-$572M
Cap. Flow
-$484M
Cap. Flow %
-33.32%
Top 10 Hldgs %
22.38%
Holding
2,744
New
72
Increased
271
Reduced
1,274
Closed
692

Sector Composition

Rank Sector Weight
1 Technology 7.4%
2 Financials 5.73%
3 Healthcare 5.57%
4 Consumer Discretionary 3.33%
5 Industrials 3.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBND icon
1126
State Street SPDR Bloomberg International Corporate Bond ETF
IBND
$463M
$37K ﹤0.01%
1,500
NECB icon
1127
Northeast Community Bancorp
NECB
$367M
$37K ﹤0.01%
3,060
TWLO icon
1128
Twilio
TWLO
$36.6B
$37K ﹤0.01%
542
-100
-16% -$7.99K
CTXS
1129
DELISTED
Citrix Systems Inc
CTXS
$37K ﹤0.01%
357
-100
-22% -$10.2K
BLES icon
1130
Inspire Global Hope ETF
BLES
$164M
$36K ﹤0.01%
1,332
+387
+41% +$12K
IHE icon
1131
iShares US Pharmaceuticals ETF
IHE
$1.64B
$36K ﹤0.01%
639
-3
-0.5% -$185
IMTB icon
1132
iShares Core 5-10 Year USD Bond ETF
IMTB
$275M
$36K ﹤0.01%
860
-1,080
-56% -$48.2K
LXP icon
1133
LXP Industrial Trust
LXP
$3.57B
$36K ﹤0.01%
805
-440
-35% -$22.9K
SPGI icon
1134
S&P Global
SPGI
$120B
$36K ﹤0.01%
118
-123
-51% -$44K
VDE icon
1135
Vanguard Energy ETF
VDE
$9.74B
$36K ﹤0.01%
362
-813
-69% -$86.5K
VRTX icon
1136
Vertex Pharmaceuticals
VRTX
$126B
$36K ﹤0.01%
127
-318
-71% -$91.5K
WDAY icon
1137
Workday
WDAY
$44.4B
$36K ﹤0.01%
240
-185
-44% -$29K
WLKP icon
1138
Westlake Chemical Partners
WLKP
$763M
$36K ﹤0.01%
1,691
-8,282
-83% -$200K
AZTA icon
1139
Azenta
AZTA
$1.48B
$35K ﹤0.01%
821
BSJP
1140
DELISTED
Invesco BulletShares 2025 High Yield Corporate Bond ETF
BSJP
$35K ﹤0.01%
1,640
CMA
1141
DELISTED
Comerica
CMA
$35K ﹤0.01%
500
-20
-4% -$1.58K
CRSP icon
1142
CRISPR Therapeutics
CRSP
$5.17B
$35K ﹤0.01%
541
-590
-52% -$42.8K
DFAS icon
1143
Dimensional US Small Cap ETF
DFAS
$15.7B
$35K ﹤0.01%
760
EIM
1144
Eaton Vance Municipal Bond Fund
EIM
$499M
$35K ﹤0.01%
3,700
-1,707
-32% -$18.2K
FTXO icon
1145
First Trust Nasdaq Bank ETF
FTXO
$311M
$35K ﹤0.01%
1,369
+192
+16% +$5.37K
FXU icon
1146
First Trust Utilities AlphaDEX Fund
FXU
$825M
$35K ﹤0.01%
1,165
-212
-15% -$7.19K
GPN icon
1147
Global Payments
GPN
$22.8B
$35K ﹤0.01%
324
-33
-9% -$4.07K
IDA icon
1148
Idacorp
IDA
$8.2B
$35K ﹤0.01%
358
JCI icon
1149
Johnson Controls International
JCI
$92.2B
$35K ﹤0.01%
720
-776
-52% -$41.1K
RNR icon
1150
RenaissanceRe
RNR
$13.4B
$35K ﹤0.01%
250
+50
+25% +$6.94K

Similar funds

Geneos Wealth Management's Q3 2022 Portfolio in Review

As of Q3 2022, Geneos Wealth Management held 2,744 positions worth $1.45B, down 28% from $2.02B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Geneos Wealth Management withdrew a net $484M in Q3 2022, closing 692 positions and reducing 1,274 holdings. Its most notable exit was Uncommon Portfolio Design Core Equity ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 8.8% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Geneos Wealth Management opened a new position in T. Rowe Price Ultra Short-Term Bond ETF worth $624K.

  • Geneos Wealth Management's largest Q3 2022 buy was T. Rowe Price Ultra Short-Term Bond ETF: 12,875 shares worth $624K.
  • Geneos Wealth Management added most to iShares Core S&P Total US Stock Market ETF in Q3 2022, an estimated $7.11M increase.
  • Geneos Wealth Management's biggest Q3 2022 reduction was Apple, cutting an estimated $43M.
  • Geneos Wealth Management fully exited Uncommon Portfolio Design Core Equity ETF in Q3 2022, selling an estimated $15.9M.
  • Geneos Wealth Management's ten largest holdings make up 22% of its $1.45B portfolio in Q3 2022.
  • Geneos Wealth Management opened 72 new positions and closed 692 in Q3 2022.
  • Geneos Wealth Management's portfolio value fell 28% quarter-over-quarter to $1.45B.

Based on Geneos Wealth Management's 13F filing for Q3 2022, filed 14 Nov 2022.